Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses
Immunologically inert or cold tumors pose a substantial challenge to the effectiveness of immunotherapy. The use of oncolytic viruses (OVs) to induce immunogenic cell death (ICD) in tumor cells is a well-established strategy for initiating the cancer immunity cycle (CIC). This process promotes the t...
Saved in:
Main Authors: | Geofrey F. Soko, Benson K. Kosgei, Stephene S. Meena, Ying Jing Ng, Huihui Liang, Bing Zhang, Qingjun Liu, Tielong Xu, Xinju Hou, Ray P. S. Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1535647/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01) -
Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
by: Tomoko Ohtani, et al.
Published: (2024-11-01) -
Improving systemic delivery of oncolytic virus by cellular carriers
by: Ziyi Peng, et al.
Published: (2024-12-01) -
The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer
by: Yi Zhao, et al.
Published: (2025-01-01) -
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
by: Yunyan Dai, et al.
Published: (2025-01-01)